PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7 | -99.9% | 200 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | -75.0% | 200 | -71.4% | 0.00% | – |
Q2 2022 | $40,000 | -69.0% | 700 | -58.8% | 0.00% | – |
Q1 2022 | $129,000 | +514.3% | 1,700 | +466.7% | 0.00% | – |
Q1 2021 | $21,000 | +23.5% | 300 | 0.0% | 0.00% | – |
Q4 2020 | $17,000 | -87.7% | 300 | -87.0% | 0.00% | -100.0% |
Q3 2020 | $138,000 | +283.3% | 2,300 | +228.6% | 0.00% | – |
Q2 2020 | $36,000 | -99.3% | 700 | -99.6% | 0.00% | -100.0% |
Q2 2016 | $5,396,000 | -49.4% | 160,000 | -20.5% | 0.02% | -46.7% |
Q1 2016 | $10,664,000 | +33.4% | 201,300 | +93.4% | 0.04% | +25.0% |
Q4 2015 | $7,993,000 | +49856.2% | 104,100 | +25925.0% | 0.04% | – |
Q3 2015 | $16,000 | -93.1% | 400 | -87.9% | 0.00% | -100.0% |
Q2 2015 | $233,000 | -52.3% | 3,300 | -40.0% | 0.00% | -50.0% |
Q1 2015 | $488,000 | -8.3% | 5,500 | -8.3% | 0.00% | 0.0% |
Q4 2014 | $532,000 | -57.1% | 6,000 | -53.1% | 0.00% | -33.3% |
Q3 2014 | $1,240,000 | +145.5% | 12,800 | +132.7% | 0.00% | +50.0% |
Q2 2014 | $505,000 | +1703.6% | 5,500 | +1275.0% | 0.00% | – |
Q1 2014 | $28,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |